Lake Zurich-based Fresenius Kabi USA said Tuesday that Dr. Seema Kumbhat has joined the company as its senior vice president and medical director.
Kumbhat and her team will manage clinical and medical strategies, as well as clinically focused education and scientific exchange with medical stakeholders. She will report to John Ducker, president and CEO of the company.
"Seema is a highly regarded physician executive and we are extremely pleased to have her join our leadership team," Ducker said. "This is an important new role for Fresenius Kabi in the U.S. as we expand our business with more clinically differentiated products and services in both our pharmaceutical and medical devices businesses."
Kumbhat has more than 20 years of health care experience. She served as global medical director of biosimilars in clinical development and medical affairs at Hospira. She also held medical affairs roles at McKesson Provider Technologies, GE Healthcare and Epic Systems Corporation.
Kumbhat is a member of the Chicago Medical Informatics Organization, the Chicago Council on Global Affairs and Chicago Innovation Mentors. She also served as program chair of BIO's personalized medicine and diagnostics group.